GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment

$1,044,000
Rakesh K. Jain · Massachusetts General Hospital · R35 · FY2018 · CA

In vivo delivery of Ab-directed CRISPR ribonucleoproteins for anal cancer immunotherapy

$1,043,843
Mary Haak-Frendscho · Spotlight Therapeutics · R44 · FY2023 · CA

Towards targeting the lymphoma microenvironment

$1,040,760
Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA

Integrative Single-Cell Atlas of Host and Microenvironment in Colorectal Neoplastic Transformation

$1,040,698
Robert J Coffey · Vanderbilt University Medical Center · U2C · FY2023 · CA

Molecular Mechanisms Regulating Mouse Mammary Gland and Human Breast Tumor Cells

$1,040,356
Esta Sterneck · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Genetically Engineered Mouse Models to Study RTK Function in Melanoma

$1,038,185
Glenn T. Merlino · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides

$1,037,336
Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity

$1,037,023
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2025 · CA

Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity

$1,037,023
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2023 · CA

Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity

$1,037,023
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA

Cellular In vivo Imaging

$1,035,876
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals

$1,035,138
Rosalie C Sears · Oregon Health & Science University · U01 · FY2024 · CA

The Cancer Target Discovery and Development Network at UCSF

$1,034,211
Michael T McManus · University Of California, San Francisco · U01 · FY2017 · CA

Targeting cancer metastasis by inhibiting curvature-induced kinase activation

$1,033,055
Bianxiao Cui · Stanford University · R01 · FY2025 · CA

Mechanisms of treatment failure in chimeric antigen receptor T cell therapy

$1,032,791
Brian Till · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA

Human Prostate Tumor Atlas Center

$1,032,520
Li Ding · Washington University · U01 · FY2024 · CA

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

$1,032,278
Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · CA

Cancer Biomaterials Engineering

$1,031,635
Matthew Wolf · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy

$1,031,566
Ming Yang · Mucommune, Llc · R44 · FY2025 · CA

Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes

$1,031,487
Scarlett L Gomez · University Of California, San Francisco · R01 · FY2022 · CA

Biomarkers and Therapeutic Targets in Tumor Microenvironment and Metastasis

$1,030,688
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Tumor Microenvironment in Cancer Progression

$1,030,688
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)

$1,030,386
Trever G Bivona · University Of California, San Francisco · U54 · FY2024 · CA

The Cancer Target Discovery and Development Network at UCSF

$1,029,182
Michael T McManus · University Of California, San Francisco · U01 · FY2020 · CA

Cancer Metabolism and Growth

$1,029,093
Wei-Xing Zong · Rbhs -Cancer Institute Of New Jersey · P30 · FY2022 · CA